36582523 35911386 36147332 - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells.

Lodi G, Gentili V, Casciano F, Romani A, Zauli G, Secchiero P, Zauli E, Simioni C, Beltrami S, Fernandez M, Rizzo R, Voltan R. Lodi G, et al. Front Pharmacol. 2022 Dec 13;13:1018761. doi: 10.3389/fphar.2022.1018761. eCollection 2022. Front Pharmacol. 2022. PMID: 36582523 Free PMC article.

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation.

Zauli G, AlHilali S, Al-Swailem S, Secchiero P, Voltan R. Zauli G, et al. Front Med (Lausanne). 2022 Jul 14;9:902713. doi: 10.3389/fmed.2022.902713. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35911386 Free PMC article. Review.

A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis.

Guo R, Zhou Y, Lin F, Li M, Tan C, Xu B. Guo R, et al. Front Pharmacol. 2022 Sep 6;13:981604. doi: 10.3389/fphar.2022.981604. eCollection 2022. Front Pharmacol. 2022. PMID: 36147332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results